L
L. Andrew Lyon
Researcher at Chapman University
Publications - 150
Citations - 13199
L. Andrew Lyon is an academic researcher from Chapman University. The author has contributed to research in topics: Particle & Nanoparticle. The author has an hindex of 64, co-authored 150 publications receiving 12340 citations. Previous affiliations of L. Andrew Lyon include Northwestern University & Georgia Institute of Technology.
Papers
More filters
Journal ArticleDOI
Doxorubicin Uptake and Release from Microgel Thin Films
TL;DR: In this paper, a spin coating, layer-by-layer assembly approach was used to prepare thin films composed of thermoresponsive poly(N-isopropylacrylamide-co-acrylic acid) (pNIPAm-AAc) microgels by alternatively exposing a 3-aminoprotrimyltrimethoxysilane (APTMS) functionalized glass substrate to polyanionic poly(nIPAm)-AAc micro gels and polycationic poly(allylamine hydrochloride) (PA
Journal ArticleDOI
Energetics of the Nanocrystalline Titanium Dioxide/Aqueous Solution Interface: Approximate Conduction Band Edge Variations between H0 = −10 and H- = +26
L. Andrew Lyon,Joseph T. Hupp +1 more
TL;DR: In this paper, a reflectance method has been used to assess conduction band edge energies (Ecb) for nanocrystalline TiO2(anatase) electrodes in contact with aqueous electrolytes.
Journal ArticleDOI
Thermally modulated insulin release from microgel thin films.
TL;DR: Investigations of thermally triggered insulin release from poly(N-isopropylacrylamide-co-acrylic acid) microgel thin films prepared by layer-by-layer (LbL) polyelectrolyte assembly confirm the capability of these films to release bursts of insulin over many cycles, and confirm that the magnitude of the release can be controlled based on film thickness.
Journal ArticleDOI
Synthesis and characterization of pH-responsive copolymer microgels with tunable volume phase transition temperatures
Justin D. Debord,L. Andrew Lyon +1 more
Journal ArticleDOI
Peptide-Functionalized Nanogels for Targeted siRNA Delivery
TL;DR: The synthesis of core/shell hydrogel nanoparticles (nanogels) with surface-localized peptides that specifically target ovarian carcinoma cell lines possessing high expression levels of the Eph2A receptor are described, and a preliminary investigation of gene silencing illustrates that nanogel-mediated delivery of siRNA targeted to the EGF receptor results in knockdown of that receptor.